BioHealth Companies Selected for Prestigious Maryland Tech Council Annual Industry Awards
The COVID-19 Pandemic didn’t stop the Maryland Tech Council from holding their 32nd Annual Industry awards. Taking this event online, MTC continued via a live virtual broadcast to recognize the top Life Sciences and Tech Companies in Maryland. Continuing their vision to propel Maryland to become the number one innovation economy for life sciences and technology in the country, Two Life Sciences Companies, and one executive was selected as Industry Awards Winners in 2020.
“We are proud to highlight and honor these companies and individuals in the life sciences and technology industries who are doing vital work to improve lives,” said MTC CEO Marty Rosendale. “With the current situation, the work of these finalists and winners is needed for now and in the future and they should be proud of what they’ve achieved.”
The BioHealth Winners:
Life Sciences Company of the Year – REGENXBIO
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve the lives of patients through the curative potential of gene therapy. Their proprietary adeno-associated virus gene delivery platform consists of exclusive rights to more than 100 novel AAV vectors. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas. Last year, the company’s technology was validated with the first FDA approval of a gene therapy that leverages the company’s NAV Technology Platform, Novartis AG’s ZOLGENSMA®.
Emerging Life Sciences Company of the Year – Adaptive Phage Therapeutics
Founded by father and son team Carl Merril and Greg Merril, Adaptive Phage Therapeutics is the culmination of 50 years of NIH research in advancing a cure for bacterial superbug infections. Their PhageBank® personalized therapy has been used to rescue numerous critically ill patients for which standard-of-care antibiotics had failed. The organization experienced a banner year last year as it was selected by market research firm CB Insights as one of the “2019 World-leading Startups” and the “#1 Biotech Startup in the World”.
Chief Executive Officer of the Year – Margot Connor, Chief Executive Officer, RoosterBio
Being open to new opportunities and taking educated risks has served RoosterBio’s CEO, Margot Connor, well. Connor is a member of the RoosterBio founding team and has grown revenues nearly 20-fold since 2014. She has led all fundraising activities and has coordinated two successful venture capital rounds including a $21.5 Series B raise in 2019 and a strategic-led mid-round investment, fueling RoosterBios’s global rise in regenerative medicine. Connor’s approachable style coupled with her relationship-driven focus is responsible for increasing the company’s staff from 6 to over 60 FTEs and landing RoosterBio on the Frederick County Best Places to Work list in 2019.
BioBuzz congratulates all the Life Science Winners in Maryland.
Latest posts by Andy Eckert (see all)
- 5 Questions with Akunna Iheanacho, Ph.D., Scientific Director, Texcell North America, Inc. - March 2, 2021
- 5 Questions with Doug White, Senior Vice President, Devices Business Unit Head, Emergent BioSolutions - February 23, 2021
- Baltimore’s Personal Genome Diagnostics and Fox Chase Cancer Center Announce Partnership to Broaden Liquid Biopsy Applications in Oncology Clinical Research - February 23, 2021
- 5 Questions with Paul Nolde, Fund Manager/Managing Director, Riverflow Growth Fund - February 16, 2021
- Taking a Job with an Emerging Biotech Presents Potential Life Changing Rewards - February 9, 2021